PT783319E - Composicoes de peptidos de muramilo que inibem a replicacao do hiv - Google Patents

Composicoes de peptidos de muramilo que inibem a replicacao do hiv

Info

Publication number: PT783319E
Authority: PT; Portugal
Prior art keywords: replication; peptides; muramilo; hiv; inhibit
Prior art date: 1994-09-26

Application number

PT95932794T

Other languages

English (en)

Inventor

Georges Bahr

Original Assignee

Vacsyn Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-26

Filing date

1995-09-26

Publication date

2003-09-30

1995-09-26 Application filed by Vacsyn Sa filed Critical Vacsyn Sa

2003-09-30 Publication of PT783319E publication Critical patent/PT783319E/pt

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
230000010076 replication Effects 0.000 title abstract 3
239000000203 mixture Substances 0.000 title 1
125000001446 muramyl group Chemical group N[C@@H](C=O)[C@@H](O[C@@H](C(=O)*)C)[C@H](O)[C@H](O)CO 0.000 abstract 2
108700024476 N-acetylmuramyl-alanylglutamine methyl ester Proteins 0.000 abstract 1
ZDSXRJABOCTJTD-HUYBTDLASA-N butyl (2r)-2-[[(2s)-2-[[(2r)-2-[(3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoyl]amino]propanoyl]amino]-5-amino-5-oxopentanoate Chemical compound CCCCOC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O ZDSXRJABOCTJTD-HUYBTDLASA-N 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
230000005764 inhibitory process Effects 0.000 abstract 1
OXSVRXKURHXDIV-OTVXWGLQSA-N methyl (2r)-2-[[(2s)-2-[2-[(2s,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxypropanoylamino]propanoyl]amino]-5-amino-5-oxopentanoate Chemical compound NC(=O)CC[C@H](C(=O)OC)NC(=O)[C@H](C)NC(=O)C(C)O[C@H]1[C@H](O)[C@@H](CO)O[C@H](O)[C@@H]1NC(C)=O OXSVRXKURHXDIV-OTVXWGLQSA-N 0.000 abstract 1
210000001616 monocyte Anatomy 0.000 abstract 1
108700017543 murabutide Proteins 0.000 abstract 1
229950009571 murabutide Drugs 0.000 abstract 1
231100000252 nontoxic Toxicity 0.000 abstract 1
230000003000 nontoxic effect Effects 0.000 abstract 1
230000001177 retroviral effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

PT95932794T 1994-09-26 1995-09-26 Composicoes de peptidos de muramilo que inibem a replicacao do hiv PT783319E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9411460A FR2724845B1 (fr)	1994-09-26	1994-09-26	Compositions de muramyl peptides capables d'inhiber jusqu'a 100% la replication d'un virus de l'immuno-deficience acquise, tel que le vih

Publications (1)

Publication Number	Publication Date
PT783319E true PT783319E (pt)	2003-09-30

Family

ID=9467271

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT95932794T PT783319E (pt)	1994-09-26	1995-09-26	Composicoes de peptidos de muramilo que inibem a replicacao do hiv

Country Status (11)

Country	Link
EP (1)	EP0783319B1 (pt)
JP (1)	JPH10506120A (pt)
AT (1)	ATE240114T1 (pt)
AU (1)	AU3569995A (pt)
CA (1)	CA2200993A1 (pt)
DE (1)	DE69530779T2 (pt)
DK (1)	DK0783319T3 (pt)
ES (1)	ES2197923T3 (pt)
FR (1)	FR2724845B1 (pt)
PT (1)	PT783319E (pt)
WO (1)	WO1996009837A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997043308A1 (en) *	1996-05-10	1997-11-20	Endorex Corporation	Lipophile derivatives of muramylpeptides for treatment of retroviral infection and induction of chemokines
FR2809106A1 (fr) *	2000-05-17	2001-11-23	Istac	Polypeptide ro/ssa-like et ses fragments et polynucleotides codant lesdits polypeptides et applications therapeutiques

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2692148B3 (fr) *	1992-06-12	1994-08-19	Vacsyn France Sa	Composition adjuvante de l'immunité humorale et à médiation cellulaire n'induisant pas de réponse vis-à-vis de déterminants auto-antigéniques.

1994
- 1994-09-26 FR FR9411460A patent/FR2724845B1/fr not_active Expired - Fee Related
1995
- 1995-09-26 AT AT95932794T patent/ATE240114T1/de not_active IP Right Cessation
- 1995-09-26 ES ES95932794T patent/ES2197923T3/es not_active Expired - Lifetime
- 1995-09-26 DK DK95932794T patent/DK0783319T3/da active
- 1995-09-26 EP EP95932794A patent/EP0783319B1/fr not_active Expired - Lifetime
- 1995-09-26 CA CA002200993A patent/CA2200993A1/en not_active Abandoned
- 1995-09-26 DE DE69530779T patent/DE69530779T2/de not_active Expired - Fee Related
- 1995-09-26 AU AU35699/95A patent/AU3569995A/en not_active Abandoned
- 1995-09-26 WO PCT/FR1995/001239 patent/WO1996009837A1/fr not_active Ceased
- 1995-09-26 PT PT95932794T patent/PT783319E/pt unknown
- 1995-09-26 JP JP8511445A patent/JPH10506120A/ja active Pending

Also Published As

Publication number	Publication date
DE69530779D1 (de)	2003-06-18
CA2200993A1 (en)	1996-04-04
FR2724845B1 (fr)	1997-01-17
DK0783319T3 (da)	2003-09-15
WO1996009837A1 (fr)	1996-04-04
ATE240114T1 (de)	2003-05-15
JPH10506120A (ja)	1998-06-16
EP0783319B1 (fr)	2003-05-14
FR2724845A1 (fr)	1996-03-29
DE69530779T2 (de)	2004-03-25
EP0783319A1 (fr)	1997-07-16
AU3569995A (en)	1996-04-19
ES2197923T3 (es)	2004-01-16

Similar Documents

Publication	Publication Date	Title
MX9204268A (es)	1994-03-31	Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
DK0608912T3 (da)	1999-02-15	Synergistiske mikrobicide sammensætninger
BR9708632A (pt)	2000-01-18	Composto calcilìticos
ES2193337T3 (es)	2003-11-01	Utilizacion de sales de estroncio para el tratamiento de la artrosis.
YU26691A (sh)	1994-05-10	BORNO KISELINSKI ADUKTI RENIJUM DIOKSIM I TEHNICIJUM-99 m DIOKSIM KOMPLEKSA I PRIBOR ZA MARKIRANJE SA TEHNICIJUMOM 99 m I/ILI RADIONUKLEIDOM RENIJUMA
ES2124479T3 (es)	1999-02-01	Composiciones biocidas.
TR200001982T2 (tr)	2001-02-21	Farmasötik vurulu salınımlı oral dozaj şekli.
ES2161279T3 (es)	2001-12-01	Nucleosidos y nucleotidos que contienen racimos de boro.
ES2083668T3 (es)	1996-04-16	Combinaciones antiviricas que contienen analogos de nucleosidos.
PT735890E (pt)	2002-09-30	Misturas de 2',3'-didesoxi-inosina e hidroxicarbamida para inibicao da disseminacao retroviral
FI962445A7 (fi)	1996-06-12	Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi
ATE252885T1 (de)	2003-11-15	Plan zur verabreichung von h+, k+-atpase inhibitoren
ATE237633T1 (de)	2003-05-15	Analogen des keratinozytenwachstumfaktors
DK0460062T3 (da)	2002-08-26	Huperzin A-analoger
GR3029370T3 (en)	1999-05-28	Compounds and methods for inhibition of hiv and related viruses
ES2170143T3 (es)	2002-08-01	Composiciones que comprenden halofantrina en una forma especial.
ES2062137T3 (es)	1994-12-16	Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
NO960775L (no)	1996-08-28	Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
ES2105605T3 (es)	1997-10-16	Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
PT783319E (pt)	2003-09-30	Composicoes de peptidos de muramilo que inibem a replicacao do hiv
MX9307203A (es)	1994-07-29	COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.
TR199700735T1 (xx)	1998-02-21	�ste�e g�re azt,DD1 ya da DDC ile birlikte ters transkritaz inhibit�r� 3T ve HIV proteaz inhibit�r� indinavirin kullan�lmas�yla HIV enfeksiyoun i�in bir arada terapi.
ES2110258T3 (es)	1998-02-01	Derivados de 1,3,5(10)-estratrieno activos por via oral.
FR2662942B1 (fr)	1992-09-18	Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae.
DK0633928T3 (da)	2004-03-22	Mikroorganismer, deres fremstilling og anvendelse